Christine Geffers
Overview
Explore the profile of Christine Geffers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruther F, Grisold A, Wechsler-Fordos A, Gropmann A, Behnke M, Hansen S, et al.
Antimicrob Resist Infect Control
. 2025 Mar;
14(1):18.
PMID: 40033434
Background: The WHO Infection Prevention and Control Assessment Framework (IPCAF) can be used for systematically evaluating infection prevention and control (IPC) practices in healthcare facilities. In 2018, a survey among...
2.
Reyle R, Schwab F, Saydan S, Behnke M, Leistner R, Gastmeier P, et al.
Antimicrob Resist Infect Control
. 2025 Feb;
14(1):17.
PMID: 40001254
Background/introduction: Antipseudomonal antibiotics are frequently used in patients admitted to hospitals. Many of these substances are classified as a reserve or watch status by the WHO. Inappropriate risk assessment of...
3.
Hering C, Leistner R, Aghdassi S, Lemke E, Gastmeier P, Geffers C, et al.
Am J Infect Control
. 2025 Feb;
PMID: 39986354
Background: Multidrug-resistant organisms pose a significant challenge in intensive care units (ICUs). Despite contact precautions (CP) being recommended as an infection prevention measure, little is known about the burden of...
4.
Saydan S, Schwab F, Holstiege J, Batzing J, Behnke M, Schneider S, et al.
J Antimicrob Chemother
. 2025 Jan;
80(3):817-824.
PMID: 39821312
Background: Antibiotic consumption is considered an important risk factor for Clostridioides difficile infection (CDI). This ecological analysis investigates the influence of outpatient antibiotic prescriptions in statutory health insurance (SHI) on...
5.
Ruther F, Gropmann A, Hansen S, Behnke M, Geffers C, Aghdassi S
Antimicrob Resist Infect Control
. 2024 Sep;
13(1):103.
PMID: 39272204
Background: The WHO Infection Prevention and Control Assessment Framework (IPCAF) is a standardized tool to assess infection prevention and control (IPC) structures in healthcare facilities. The IPCAF reflects the eight...
6.
Kramer T, Brodzinski A, Paul M, Drexler H, Scheithauer S, Geffers C
Dtsch Arztebl Int
. 2024 Sep;
121(21):715-724.
PMID: 39262118
Background: Single-use medical gloves achieve their purpose only when properly used. Proper use also helps avoid undesired consequences such as excessive waste and CO2 emissions, as well as inadequate hand...
7.
Rademacher J, Ewig S, Grabein B, Nachtigall I, Abele-Horn M, Deja M, et al.
Infection
. 2024 Aug;
52(6):2531-2545.
PMID: 39115698
Purpose: This executive summary of a German national guideline aims to provide the most relevant evidence-based recommendations on the diagnosis and treatment of nosocomial pneumonia. Methods: The guideline made use...
8.
Aghdassi S, Saydan S, Behnke M, Clausmeyer J, Gastmeier P, Geffers C
Euro Surveill
. 2024 Mar;
29(11).
PMID: 38487888
BackgroundSurveillance of lower respiratory tract infections (LRTI) of operated patients conventionally focuses on intubated patients in intensive care units (ICU). Post-operative immobilisation increases the risk of LRTI not associated with...
9.
Aghdassi S, Hansen S, Pena Diaz L, Gropmann A, Saydan S, Geffers C, et al.
Dtsch Arztebl Int
. 2024 Mar;
121(9):277-283.
PMID: 38471129
Background: A national point prevalence survey (PPS) of healthcare-associated infections (HAI) and antibiotic use (AU) was carried out in Germany in 2022 in the framework of the European PPS conducted...
10.
Klassert T, Zubiria-Barrera C, Denkel L, Neubert R, Schneegans A, Kulle A, et al.
Microbiol Spectr
. 2024 Feb;
12(3):e0307823.
PMID: 38353551
An increasing amount of evidence has linked critical illness with dysbiotic microbiome signatures in different body sites. The disturbance of the indigenous microbiota structures has been further associated with disease...